Sangamo Biosciences, Inc. (SGMO) Tops Q2 EPS by 4c
Tweet
Share
E-mailGet Alerts SGMO Hot Sheet
Price: $0.18 --0%
Revenue Growth %: -5.7%
Financial Fact:
Collaboration agreements: 2.73M
Today's EPS Names:
DTGI, CRMT, MAYS, More
Revenue Growth %: -5.7%
Financial Fact:
Collaboration agreements: 2.73M
Today's EPS Names:
DTGI, CRMT, MAYS, More
Join SI Premium – FREE
Sangamo Biosciences, Inc. (NASDAQ: SGMO) reported Q2 EPS of ($0.10), $0.04 better than the analyst estimate of ($0.14). Revenue for the quarter came in at $10.4 million versus the consensus estimate of $7.84 million.
For earnings history and earnings-related data on Sangamo Biosciences, Inc. (SGMO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- SanDisk and Micron surge as Apple confirms memory price pass-through
- FedEx (FDX) PT Lowered to $424 at Bernstein SocGen Group
- Pfizer reafffirms 2026 guidance after CFO transition announcement
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
